Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuya Nagano

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Respiratory Investigation|December 3, 2024
Biologics treatment for eosinophilic chronic rhinosinusitis complicated by bronchial asthma: Narrative reviewTatsuya Nagano
Journal of Thoracic Disease|August 14, 2025
Robust evidence of the rapid efficacy of benralizumabTatsuya Nagano
International Journal of Molecular Sciences|March 11, 2023
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease ProgressionWiwin Is Effendi, Tatsuya Nagano
Biomedicines|May 16, 2023
Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA MethylationWiwin Is Effendi, Tatsuya Nagano
International Journal of Molecular Sciences|January 11, 2022
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection TimeWiwin Is Effendi, Tatsuya Nagano
International Journal of Molecular Sciences|October 13, 2021
The Crucial Role of NLRP3 Inflammasome in Viral Infection-Associated Fibrosing Interstitial Lung DiseasesWiwin Is Effendi, Tatsuya Nagano
International Journal of Molecular Sciences|June 10, 2022
Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the BridgeWiwin Is Effendi, Tatsuya Nagano
Molecules (Basel, Switzerland)|September 5, 2020
Novel Multitarget Therapies for Lung Cancer and Respiratory DiseaseMasako Yumura, Tatsuya Nagano, Yoshihiro Nishimura
In Vivo (Athens, Greece)|March 4, 2022
Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant AsthmaTakeo Nakajima, Tatsuya Nagano, Yoshihiro Nishimura
Cells|November 18, 2018
Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment StrategyTatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Respiratory Investigation|December 3, 2024
Biologics treatment for eosinophilic chronic rhinosinusitis complicated by bronchial asthma: Narrative reviewTatsuya Nagano
Journal of Thoracic Disease|August 14, 2025
Robust evidence of the rapid efficacy of benralizumabTatsuya Nagano
International Journal of Molecular Sciences|March 11, 2023
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease ProgressionWiwin Is Effendi, Tatsuya Nagano
Biomedicines|May 16, 2023
Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA MethylationWiwin Is Effendi, Tatsuya Nagano
International Journal of Molecular Sciences|January 11, 2022
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection TimeWiwin Is Effendi, Tatsuya Nagano
International Journal of Molecular Sciences|October 13, 2021
The Crucial Role of NLRP3 Inflammasome in Viral Infection-Associated Fibrosing Interstitial Lung DiseasesWiwin Is Effendi, Tatsuya Nagano
International Journal of Molecular Sciences|June 10, 2022
Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the BridgeWiwin Is Effendi, Tatsuya Nagano
Molecules (Basel, Switzerland)|September 5, 2020
Novel Multitarget Therapies for Lung Cancer and Respiratory DiseaseMasako Yumura, Tatsuya Nagano, Yoshihiro Nishimura
In Vivo (Athens, Greece)|March 4, 2022
Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant AsthmaTakeo Nakajima, Tatsuya Nagano, Yoshihiro Nishimura
Cells|November 18, 2018
Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment StrategyTatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
Pageof 15